- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00619086
Steroid Before Thyroidectomy
June 6, 2008 updated by: University of Bern
Does a Single Dose of Steroid Before Thyroidectomy Improve Postoperative Nausea, Pain and Vocal Function?
We evaluated the effects of giving a single dose of steroid before thyroid surgery in a single institutional, double-blinded, randomized controlled trial.
Postoperative nausea, pain, and vocal function were significantly improved after steroid administration compared to controls.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bern, Switzerland, 3010
- Department of visceral- and transplant surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing thyroid surgery for benign disease
Exclusion Criteria:
- Depression
- Chronic pain disorder
- Insulin dependent diabetes mellitus
- History of PONV
- Pregnancy
- Age < 18 years
- Received antiemetic therapy within 48 hours
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: A, 1
Placebo 45 minutes prior to surgery
|
100 ml sodium chloride i.v.
45 minutes prior to surgery
|
|
Active Comparator: A, 2
8 mg Dexamethasone 45 minutes prior to surgery
|
8 mg Dexamethason i.v.
45 minutes prior to surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Nausea
Time Frame: 0-72 hours postoperative
|
0-72 hours postoperative
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain, vocal function
Time Frame: 0-72 hours postoperative
|
0-72 hours postoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephan A. Vorburger, MD, Dept of visceral- and transplant surgery, University Hospital Bern
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2005
Study Completion (Actual)
June 1, 2007
Study Registration Dates
First Submitted
February 7, 2008
First Submitted That Met QC Criteria
February 19, 2008
First Posted (Estimate)
February 20, 2008
Study Record Updates
Last Update Posted (Estimate)
June 9, 2008
Last Update Submitted That Met QC Criteria
June 6, 2008
Last Verified
June 1, 2008
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- KEK_49_05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Surgery for Benign Disease
-
Gangnam Severance HospitalCompletedPatients Undergoing Thyroid Surgery for NeoplasmKorea, Republic of
-
Ethicon Endo-SurgeryCompletedBenign or Malignant Disease Indicated for ColectomyUnited States, Belgium, United Kingdom
-
University Hospital, Strasbourg, FranceUnknownWomen Who Undergo a Laparoscopic Hysterectomy for Benign Disease.France
-
Samsung Medical CenterCompletedGynecologic Laparoscopic Surgery for Benign Adnexa DiseaseKorea, Republic of
-
Ethicon Endo-Surgery (Europe) GmbHCompletedBenign Thyroid DiseaseItaly, Belgium
-
Suez UniversityNot yet recruiting
-
Minia UniversityCompletedBenign Thyroid NoduleEgypt
-
Hospital de Concentracion Norte de PetroleosCompletedAbdominal Hysterectomy for Benign DiseaseMexico
-
University Hospital, GhentUniversitaire Ziekenhuizen KU Leuven; AZ Sint-Jan AVRecruitingBenign Thyroid NoduleBelgium
-
Unity Health TorontoCompletedLaparoscopic Hysterectomy for Benign ConditionsCanada
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States